Compound 2356
Identifiers
- Canonical SMILES:
COc1cc2c(cc1OCCCN1CCCC1)N=C(N)C21CCCC1
- IUPAC name:
5'-methoxy-6'-[3-(pyrrolidin-1-yl)propoxy]spiro[cyclopentane-1,3'-indol]-2'-amine
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
SPIN1 / H3 | 6.12 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 343.23 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 2.64 | |||
TPSA | 62.89 | |||
RB | 6 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/acs.jmedchem.9b00562 | 11a | SPIN1 Q9Y657 |
Q5TEC6 Q5TEC6 |
Biochemical assay | AlphaLISA | pIC50 (half maximal inhibitory concentration, -log10) | 6.12 |
Ta | Structure | Name | Drugbank ID |
---|